Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06480227 · ClinicalTrials.gov registry record · NA
Trial of Transurethral Bulking Agent Injection Versus Single-Incision Sling for Stress Urinary Incontinence
A NA study of Urinary Incontinence and Stress Urinary Incontinence, sponsored by NICHD Pelvic Floor Disorders Network.
- Recruiting
- Registry status
- NA
- Development phase
- 358
- Enrollment target
- 7
- Study locations
NCT06480227 is a NA study of Urinary Incontinence and Stress Urinary Incontinence that is actively recruiting participants, run by NICHD Pelvic Floor Disorders Network. The registered enrollment target is 358 participants, above the 255-participant average among 48 other Urinary Incontinence trials with a reported enrollment target (40% higher). The trial reports 7 study locations across 6 states.
The verdict
NCT06480227, a NA study of Urinary Incontinence and Stress Urinary Incontinence, is actively recruiting participants, sponsored by NICHD Pelvic Floor Disorders Network.
- RECRUITING
- Registry status
- NA
- Development phase
- 358 participants
- Enrollment target
- 7
- Study locations
Study Summary
This is a multicentered, double-blind, randomized controlled, surgical trial of 358 women with inadequate symptom relief of stress urinary incontinence (SUI) or stress predominant mixed urinary incontinence (MUI) after conservative care. The Primary Aim is to determine the comparative effectiveness (as defined by "much" or "very much" better on PGI-I) of transurethral bulking agent (TBA) \[for 1 or 2 injections in 12 months\] vs. single-incision sling (SIS) 12 months after treatment intervention in women with predominant stress urinary incontinence (SUI).
Conditions Studied
Interventions
- DEVICE Solyx Single-incision Sling
- DEVICE Bulkamid Transurethral Bulking Agent
Study Locations (7)
California
- University of California at San Diego - La Jolla
- Kaiser Permanente -- San Diego - San Diego
Illinois
- University of Chicago - Chicago
North Carolina
- Duke University, Duke Division of Urogynecology and Reconstructive Pelvic Surgery - Durham
Pennsylvania
- University of Pennsylvania - Philadelphia
Rhode Island
- Brown/ Women and Infants Hospital of Rhode Island, Division of Urogynecology and Reconstructive Pelvic Surgery - Providence
Texas
- University of Texas Southwestern Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 358 participants |
| Start Date | 2024-08-28 |
| Est. Completion | 2030-01-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06480227
The ClinicalTrials.gov registry entry for NCT06480227 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 358 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 255-participant average among 48 other Urinary Incontinence trials with a reported enrollment target (40% higher). The listed sponsor is NICHD Pelvic Floor Disorders Network, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Urinary Incontinence appearing as the primary indexed condition, and to 2 interventions - of which Solyx Single-incision Sling is the first listed.
NCT06480227 reports 7 study locations spanning 6 distinct geographic areas - top geographies include California, Illinois, North Carolina.
Frequently Asked Questions
What is clinical trial NCT06480227 about?
NCT06480227 is a clinical study titled "Trial of Transurethral Bulking Agent Injection Versus Single-Incision Sling for Stress Urinary Incontinence". This is a multicentered, double-blind, randomized controlled, surgical trial of 358 women with inadequate symptom relief of stress urinary incontinence (SUI) or stress predominant mixed urinary incontinence (MUI) after conservative care. The Primary Aim is to determine the comparative effectiveness...
What is the current status of trial NCT06480227?
This trial is currently recruiting. It is a NA study. The enrollment target is 358 participants. The study started on 2024-08-28. Estimated completion is 2030-01-01.
What conditions does trial NCT06480227 study?
This clinical trial studies the following conditions: Urinary Incontinence, Stress Urinary Incontinence, Mixed Urinary Incontinence.
What interventions are being tested in trial NCT06480227?
The interventions under investigation include: Solyx Single-incision Sling (DEVICE), Bulkamid Transurethral Bulking Agent (DEVICE).
Who is sponsoring clinical trial NCT06480227?
This trial is sponsored by NICHD Pelvic Floor Disorders Network, which has 17 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06480227 being conducted?
This trial has 7 study locations across California, Illinois, North Carolina, Pennsylvania, Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urinary Incontinence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
TENS Analgesia During Outpatient Urethral Bulking for Stress Urinary Incontinence.
RECRUITING · NA
-
Adjustable Continence Therapy (ACT) for the Treatment of Female SUI
RECRUITING · NA
-
Improving Overactive Bladder Treatment Access and Adherence
RECRUITING · NA
-
Training for Urinary Leakage Improvement After Pregnancy
RECRUITING · NA
-
Home Biofeedback Therapy for Dyssynergic Defecation, Fecal Incontinence and Urinary Incontinence
RECRUITING · NA
-
BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Sexual Function Among Perimenopausal and Postmenopausal Women
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.